Stable HIV‐1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study

OBJECTIVES: Dolutegravir (DTG) is a highly effective integrase inhibitor with a strong genetic resistance barrier and a potential role in simplified HIV maintenance treatment. We assessed the feasibility of DTG maintenance monotherapy and measured HIV reservoirs on DTG monotherapy. METHODS: An inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Sculier, D, Doco‐Lecompte, T, Yerly, S, Metzner, KJ, Decosterd, LA, Calmy, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120531/
https://www.ncbi.nlm.nih.gov/pubmed/29932298
http://dx.doi.org/10.1111/hiv.12626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120531/
https://www.ncbi.nlm.nih.gov/pubmed/29932298
http://dx.doi.org/10.1111/hiv.12626

Ejemplares similares